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Recent genome-wide association studies have linked polymorphisms in two atophagy genes, Atg16L1 and
IRGM, with Crohn’s Disease. Now, experiments with Atg16L1 transgenic mice indicate multiple roles for
autophagy in inflammatory bowel disease via effects on Paneth cells, a runaway inflammasome, and the
proinflammatory cytokine IL-1b.Autophagy is a cytoplasmic homeostasis
process that cleanses the interior of all
eukaryotic cells. It turns over stable or
aggregated proteins, removes surplus or
damaged organelles, and eliminates intra-
cellular microbes (Levine and Deretic,
2007). A hallmark feature of autophagy is
the formation within the cytosol of mem-
brane crescents corralling cytoplasmic
targets into the double-membrane-bound
autophagosome, an emblematic feature
of autophagy. Autophagosomes fuse with
lysosomes, thus degrading the captured
cargo. Autophagy plays a role in aging, de-
generative diseases, cancer, and immu-
nity. In its immunological manifestations
(Levine and Deretic, 2007), autophagy
promotes MHC II antigen presentation of
endogenous antigens, acts as an effector
of Th1/Th2 polarization, governs T cell
repertoire and homeostasis, and acts as
an antimicrobial mechanism that can be
activated by Toll-like receptors (TLR)
(Delgado et al., 2008).
Autophagy is best understood in yeast,
which was the origin of the Atg nomencla-
ture used for many components of the
pathway. Autophagosome formation in
eukaryotes is driven by two key Atg con-
jugation systems: (1) a covalent protein
conjugate, Atg5-Atg12, noncovalently
complexed with Atg16 (or Atg16L1 in
mammals); and (2) a protein-lipid conju-
gate of Atg8 (LC3 in mammals) with phos-
phatidylethanolamine at its C terminus.
The Atg5-Atg12/Atg16 complex stimu-
lates LC3 lipidation. In this process,
Atg16L1 ‘‘marks the spot’’ where the con-
jugation systems converge to generate
nascent autophagosomes (Fujita et al.,
2008). Mammalian Atg16L1 contains three
distinct regions (Figure 1A): the N-terminalportion interacting with Atg5, the coiled-
coil domain (CCD) necessary for Atg16L1
oligomerization and Atg5-Atg12 associa-
tion, and the WD repeat domain, which
is absent in yeast.
Recent genome-wide association
(GWA) studies have linked autophagy
with Crohn’s Disease (CD), a major form
of chronic inflammatory bowel disease
(Xavier and Podolsky, 2007). CD develops
predominantly at anatomical sites (termi-
nal ileum and colon) where commensal
bacteria dramatically increase in mass
(Xavier and Podolsky, 2007). It is believed
that CD results from a ‘‘perfect storm’’ of
ongoing challenge by normal gut flora and
an aberrant innate immunity response.
The latest GWA breakthroughs have
expanded the role of innate immunity
components beyond the already impli-
cated Nod2 (Kanneganti et al., 2007) to
include autophagy based on association
with Atg16L1 (Cadwell et al., 2008; Saitoh
et al., 2008) and an autophagy-linked
factor, IRGM, involved in clearing bacteria
(Singh et al., 2006).
Until the two new reports from the
groups of Shizuo Akira (Saitoh et al.,
2008) and Herbert Virgin (Cadwell et al.,
2008), little was known (but much was be-
ing guessed) about the role of Atg16L1
and autophagy in CD. The two teams gen-
erated different Atg16L1 transgenic mice
and came to diverse but not mutually ex-
clusive conclusions. Saitoh et al. (2008)
generated Atg16L1 DCCD mice, with the
Atg16L1 gene deleted for the CCD do-
main. The Atg16L1 DCCD mice die within
1 day of birth, a phenomenon previously
seen with the Atg5/ knockout mice.
Atg16L1-deficient MEFs were null for
autophagy. Saitoh et al. tested Atg16LDevelopmental Cell 15,DCCD fetal liver-derived macrophages
for proinflammatory cytokine production
in response to LPS and found elevated
IL-1b production (Figures 1B and 1C). Ex-
posure of Atg16L1DCCD macrophages to
commensal bacteria such as Escherichia
coli elicited abnormally high IL-1b pro-
cessing. Next, lethally irradiated mouse
chimeras reconstituted with Atg16L1
DCCD embryonic liver cells were sub-
jected to experimentally induced colitis
with dextran sulfate. The result was a
100% 10-day mortality of the Atg16L1
DCCD mouse chimeras, elevated IL-1b
and IL-18 in the sera, and distal colon
inflammation. Death was avoided and
pathology was reversed by IL-1b- and
IL-18-neutralizing antibodies (Saitoh
et al., 2008).
Can elevated IL-1b help understand CD
pathogenesis? The Atg16L1 DCCD ef-
fects on IL-1b are reminiscent of CD Nod2
variants, which also elicit elevated IL-1b
in murine models (Kanneganti et al.,
2007). The components of IL-1b signaling
are often abnormal in intestinal tissue
specimens from inflammatory bowel dis-
ease patients, and increased IL-1b may,
among other effects, increase epithelial
barrier permeability (Al-Sadi et al., 2008),
possibly enhancing microbial product
translocation. Complementing these find-
ings, the elegant studies by Saitoh et al.
have also uncovered a previously unap-
preciated role for autophagy in inflamma-
some function. The inflammasome
occupies a special place in the innate im-
munity hall of fame. Upon proper stimula-
tion, the inflammasome proteolytically
converts inactive substrates into biologi-
cally highly active inflammation media-
tors, which includes the processing ofNovember 11, 2008 ª2008 Elsevier Inc. 641
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out that autophagy downregu-
lates this system by a posttrans-
lational mechanism requiring
reactive oxygen species and a
TLR binding adaptor molecule
known as TRIF. Although the ex-
act details are not available yet,
it would be interesting to know
whether autophagy targets the
inflammasome or its substrates
for degradation.
Anticipating that an outright
Atg16L1 knockout would be
lethal, Cadwell et al. (2008) took
a different approach and gener-
ated hypomorphic Atg16L1HM
mice expressing Atg16L1 at
30% of the wild-type levels.
The strategy resulted in viable
Atg16L1HM progeny. Autophagy
was reduced (but not completely
eliminated) as shown in
Atg16L1HM MEFs and ileal spec-
imens. Although Atg16L1 is ex-
pressed in both the crypt and
the villus of the ileum (Figure 1),
changes were observed only in
Paneth cells, which have a previ-
ously suspected role in CD
(Xavier and Podolsky, 2007).
Paneth cells are found at bottom
of ileal crypts (Figure 1B), and exocytose
granules containing antimicrobial prod-
ucts—a-defensins, lysozyme, and
secretory phospholipase A2. These anti-
microbials are believed to protect the
neighboring stem cells from microbial
insults and keep gut microbial flora under
check. Paneth cells in the Atg16L1HM
ileum contained fewer granules and
showed diffuse cytoplasmic lysozyme
staining (Figure 1C), leading to the conclu-
sion that autophagy affects Paneth cell
function. As autophagy intersects with
the lysosomal pathway, and secretory
granules often correspond to specialized
lysosomes, autophagy could affect the
biosynthesis or quality control of Paneth
cell granules. Alternatively, the cells with
fewer granules might be a result of Paneth
cell exhaustion, compensating for
changes elsewhere in the epithelium. As
with the studies by Saitoh et al., the
Atg16L1HM findings by Cadwell et al.
showed parallels with Nod2 effects:
expression in CD-like mutant Nod2
mouse alleles affects Paneth cells by
reducing these cells’ Nod2-dependent
production of a-defensins (Kanneganti
et al., 2007).
How do the elegant studies with
Atg16L1 DCCD and Atg16L1HM mice re-
late to the actual Atg16L1 alleles in CD pa-
tients? The CD risk allele Atg16L1*300A is
a single amino acid polymorphism (an Ala
residue at the position 300 between CCD
and WD; Figure 1A). In cultured epithelial
cells, the Atg16L1*300A allele had no
effect on housekeeping autophagy but
caused a defective autophagic response
to invasive bacteria (Figures 1B and 1C)
(Kuballa et al., 2008). In addition,
the Atg16L1*300A protein was
unstable in infected epithelial
cells, a feature not seen with the
protective Atg16L1*300T allele.
Thus, Atg16L1*300A has a hypo-
morphic phenotype (Kuballa
et al., 2008), meaning that
Atg16L1HM mice may recapitu-
late some aspects of this
Atg16L1 CD risk allele. Collec-
tively, these studies affirm sev-
eral long-term or recent notions
about CD and provide insight
into the role of autophagy in this
disease, an aspect that will
become more complete once
the effects of other autophagy
factors, including IRGM, are
revealed.
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Figure 1. Atg16L Roles in Crohn’s Disease
(A) Schematic of Atg16L1 features.
(B) Normal ileal crypt of Lieberku¨hn (CL) and villus (V). AØ, autophago-
some (detected in cell culture); E, enterocyte; E.c., adherent-invasive
E. coli; G, Goblet cell; MØ, macrophage; P, Paneth cell; SCZ, stem
cell zone; TJ, tight junction.
(C) Dotted arrow, microbial translocation (proposed). 1.–3., effects of
ATG16L1 mutations. 1. Increased IL-1b activation (in macrophages
from Atg16L1 transgenic mice) accompanied by experimentally
induced intestinal inflammation and mortality in vivo (not shown).
IL-1b can dilate tight junctions (demonstrated in vitro) and may en-
hance microbial translocation. 2. Fewer granules or diffuse granule
contents in the cytoplasm of Paneth cells (in ileal sections from
Atg16L1HM hypomorphic mice and uninvolved portions of ileocolic
resection specimens from CD patients). 3. Reduced autophagy of
invasive bacteria (in cultured epithelial cells rendered Atg16L1*300A
by siRNA knockdown of endogenous Atg16L1 and complemented
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